Residential College | false |
Status | 已發表Published |
“Swiss Army Knife” black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment | |
Guowang Cheng1; Zhongjun Li3; Yujing Liu2; Rui Ma2; Xiaojia Chen4; Wen Liu4; Yafang Song2; Yuan Zhang3; Guangtao Yu5; Zhenfeng Wu1; Tongkai Chen2 | |
2022-12-16 | |
Source Publication | Journal of Controlled Release |
ISSN | 0168-3659 |
Volume | 353Pages:752-766 |
Abstract | The combination of excessive reactive oxygen species (ROS) levels, neuroinflammation, and pathogenic protein aggregation disrupt the homeostasis of brain microenvironment, creating conditions conducive to the progression of Parkinson's disease (PD). Restoring homeostasis by remodeling the brain microenvironment could reverse this complex pathological progression. However, treatment strategies that can induce this effect are currently unavailable. Herein, we developed a “Swiss Army Knife” nanodelivery platform consisting of matrine (MT) and polyethylene glycol-modified black phosphorus nanosheets (BP) that enables PD treatment by restoring brain microenvironment homeostasis. Under NIR irradiation, the photothermal effect induced by BP allowed the nanomedicine to cross the blood-brain barrier (BBB) and entered the brain parenchyma. In PD brains, the biological effects of BP and MT resulted in the removal of excess ROS, effective reduction of neuroinflammation, decreased aggregation of pathogenic proteins, and improved neurotransmitter delivery, eventually restoring dopamine levels in the striatum. This study demonstrated the effective capacity of a BP-based nanodelivery platform to enter the brain parenchyma and trigger multiple neuropathological changes in PD brains. The platform serves as a safe and effective anti-PD nanomedicine with immense clinical potential. |
Keyword | Parkinson's Disease Neuroinflammation Α-synuclein Blood-brain Barrier Black Phosphorus Nanosheets Neuroprotection |
DOI | 10.1016/j.jconrel.2022.12.024 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Chemistry ; Pharmacology & Pharmacy |
WOS Subject | Chemistry, Multidisciplinary ; Pharmacology & Pharmacy |
WOS ID | WOS:000914702100001 |
Publisher | ELSEVIERRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS |
Scopus ID | 2-s2.0-85144304212 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | THE STATE KEY LABORATORY OF QUALITY RESEARCH IN CHINESE MEDICINE (UNIVERSITY OF MACAU) Institute of Chinese Medical Sciences |
Corresponding Author | Yuan Zhang; Guangtao Yu; Zhenfeng Wu; Tongkai Chen |
Affiliation | 1.Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China 2.Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China 3.Department of Neurosurgery & Shenzhen Key Laboratory of Neurosurgery, The First Affiliated Hospital of Shenzhen University/Shenzhen Second People's Hospital, Shenzhen University, Shenzhen 518035, China 4.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China 5.Stomatological Hospital, Southern Medical University, Guangzhou 510280, China |
Recommended Citation GB/T 7714 | Guowang Cheng,Zhongjun Li,Yujing Liu,et al. “Swiss Army Knife” black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment[J]. Journal of Controlled Release, 2022, 353, 752-766. |
APA | Guowang Cheng., Zhongjun Li., Yujing Liu., Rui Ma., Xiaojia Chen., Wen Liu., Yafang Song., Yuan Zhang., Guangtao Yu., Zhenfeng Wu., & Tongkai Chen (2022). “Swiss Army Knife” black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment. Journal of Controlled Release, 353, 752-766. |
MLA | Guowang Cheng,et al."“Swiss Army Knife” black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment".Journal of Controlled Release 353(2022):752-766. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment